Giovanni Roti

6PUBLICATIONS
61CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPharmaceutical delivery technologiesTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 31, 2026
Survival after first relapse in marginal zone lymphomas: Prospective data from the international observational NF10 study.

|Dec 13, 2024
Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC.

Giulia Mazzaschi, Cristina Marrocchio, Lucas Moron Dalla Tor

|Jun 13, 2024
Acute lymphoblastic leukaemia.

Luca Pagliaro, Sai-Juan Chen, Daniel Herranz

|Jun 04, 2024
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML.

Matteo Marchesini, Andrea Gherli, Elisa Simoncini

|Jan 07, 2021
Targeting oncogenic Notch signaling with SERCA inhibitors.

Luca Pagliaro, Matteo Marchesini, Giovanni Roti

|Dec 03, 2019
Bilateral tonsillar infiltration of T-cell prolymphocytic leukemia.

Ilaria Bertaggia, Sabrina De Stefano, Filippo Di Lella

Pageof 1

Frequent Collaborators

2 joint publications

Lucas Moron Dalla Tor

2 joint publications

Luca Pagliaro

2 joint publications

Federico Quaini

2 joint publications

Bruno Lorusso